Our founder, Mark Crozier, is a veteran and retired first responder who understands the everyday struggles these targeted groups face in their line of work. Veterans and first responders can suffer from PTSD, depression, sleep apnea, chronic pain, and much more as a direct result of their sacrifice, stress, and devotion to protecting our great nation. Crozier started Royal Emerald Pharmaceuticals to combat the medical issues our veterans and first responders face during and after their service.
Royal Emerald Pharmaceuticals is a veteran and first responder owned company whose focus is on providing veterans and first responders with the proper care and attention they truly deserve. We are here to help our veterans and first responders by using non-addictive medicines to treat their ailments. Our goal is to help them with their health and medical needs, as they have sacrificed so much for the betterment of our country and communities.
A major medical problem we have in modern society is the prevalence of opioid addiction. Large companies and corporations are profiting handsomely from the sale of opioids. However, these drugs are highly addictive, leading to the current opioid crisis that plagues our nation. In 2017, the United States had more than 70,000 deaths related to opioid induced drug overdose.
Royal Emerald Pharmaceuticals is dedicated to producing drugs that are non-addictive with few to no side effects, while also being effective at alleviating the primary targeted ailments that our customers may face. Our extensive research into alternative medicines and strict adherence to the most current and innovative quality processes will ensure that our customers will be safe from many harmful side effects that contemporary, opioid-based medicines create.
We have chosen the city of Desert Hot Springs as home for our first pharmaceutical research and manufacturing facility. The facility will supplement specific government research contracts and has been designed so that it can quickly increase capacity and production incrementally, according to demand.
This facility will help the research community by bulk manufacturing, procuring, processing, analyzing, storing, and distributing botanical raw materials for research. This includes:
The company envisions a corporate campus and manufacturing facility situated on more than 200 acres of land and up to three million square feet of office and manufacturing space. The campus will include a parking structure and other amenities.
The entire facility and campus will utilize the latest technology in cogeneration to produce energy-efficient and environmentally friendly buildings.
The three-phase plan will have continual construction in order to meet growth demands.
Royal Emerald Pharmaceuticals is also working with architects and leading edge construction companies possessing vast experience in the design, construction, and project management of efforts to create large buildings with complicated utility and resource requirements, to include agronomy structures. These building designs have contained the latest technology and innovations in lighting, utilities, and growing efficiencies. Many of these construction projects have been based internationally in Canada and England.
